Skip to main content
. 2020 Jan 30;59(16):6342–6366. doi: 10.1002/anie.201900585

Figure 19.

Figure 19

A) NAV2729, a small molecule inhibitor developed for the Arf GTPases. B) Interfacial inhibitors targeting the Arf/ArfGEF subfamily. Toxicophores/structural alerts are shown in purple.